Clinical Trial Update: Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effect of adding ezetimibe to statin therapy on postprandial lipemia in people with type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postprandial Lipemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• Statin class (statin)

Snippet

Sponsor: Federico II University | Conditions: Postprandial Lipemia, Type 2 Diabetes | Phase 4 | Status: COMPLETED